SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, has entered into a collaboration with DiscoverX, an innovative life science company that supplies cell-based assays and services for drug discovery and development. Under the terms of the agreement, SGS and DiscoverX will work together to provide simple and qualified assays for functional comparability, for […]
Venlo, The Netherlands, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced that it has decided to submit a conditional voluntary takeover offer to the shareholders of Exiqon A/S (NASDAQ OMX Copenhagen: EXQ) to purchase all shares in Exiqon. The acquisition is expected to expand QIAGEN’s leadership position in Sample to Insight solutions for […]
Copenhagen, – Exiqon A/S (Nasdaq Copenhagen: “EXQ”) announced that QIAGEN N.V (“QIAGEN”) has informed the Company that it will submit a voluntary conditional public takeover offer to buy the entire share capital of Exiqon A/S for DKK 18 per share of nominal DKK 1.00 (‘Offer Price’). This will be documented by an Offer Document, which […]
PARIS — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, and the French National Institute of Health and Medical Research (Inserm), the only French public research institute to focus entirely on human health and the largest in Europe, […]
SAN DIEGO, – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting metalloproteins, and Active Motif, a leader in developing tools to enable epigenetics research, announced today a research collaboration aimed at advancing epigenetic research related to the family of iron-containing lysine demethylases known as Jumonji KDMs. The […]
DNASTAR announced that Inhibrx has entered into an agreement supporting an organization-wide site license of DNASTAR Lasergene software. This license provides access to DNASTAR software for all employees of Inhibrx. John Timmer Ph.D., the Research Director of Inhibrx commented, “After using Lasergene software in-house to meet our day to day sequence analysis needs, it became […]
WALTHAM, Mass. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, issued the following statement regarding Affymetrix, Inc.’s (NASDAQ: AFFX) press release dated March 28, 2016: JP Morgan is acting as financial advisor to Thermo Fisher, and Wachtell, Lipton, Rosen & Katz is serving as legal counsel.“We are pleased that the […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or “the Company”) today announced that the Company’s Board of Directors (the “Board”), in consultation with its legal and financial advisors, has determined that the unsolicited merger proposal submitted by Origin Technologies Corporation, LLC (“Origin”) on March 22, 2016 does not constitute a Superior Proposal, as […]
CINCINNATI, – Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) announced that it has completed the acquisition of Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. Headquartered in Billerica, Massachusetts (near Boston), Magellan pioneered the engineering, development and manufacturing of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or the “Company”) announced that the Company’s Board of Directors has informed Origin Technologies Corporation, LLC (“Origin”) that the Company will engage in discussions with Origin regarding its unsolicited merger proposal submitted on March 22, 2016 to acquire the Company for $17.00 per share in an […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
